-$0.30 EPS Expected for Intec Pharma (NTEC) This Quarter


Wall Street brokerages expect that Intec Pharma will post earnings of per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Intec Pharma's earnings.



from Biotech News